StockWatch
·
Biotechnology: Pharmaceutical Preparations
Quarterly ResultMay 7, 2026, 04:10 PM

Viatris Q1 Net Earnings $176.4M, Sales $3.51B

AI Summary

Viatris Inc. reported a significant turnaround in its first quarter 2026 financial results, achieving net earnings of $176.4 million compared to a substantial net loss in the prior year, primarily due to the absence of goodwill impairment. Net sales increased to $3.51 billion, driven by growth in Developed Markets and Greater China. The company also declared a quarterly cash dividend of $0.12 per share.

Key Highlights

  • Net earnings were $176.4 million in Q1 2026, a significant improvement from a $3,042.0 million net loss in Q1 2025.
  • Basic earnings per share (EPS) was $0.15 in Q1 2026, up from a $(2.55) loss per share in Q1 2025.
  • Net sales increased by 8.2% to $3,509.7 million in Q1 2026 from $3,243.2 million in Q1 2025.
  • Developed Markets net sales grew by 6.8% to $2,020.8 million in Q1 2026.
  • Greater China net sales increased by 22.4% to $680.1 million in Q1 2026.
  • Cash provided by operating activities was $388.3 million, down from $535.5 million in Q1 2025.
  • The company declared a quarterly cash dividend of $0.12 per common share.
  • Divestiture-related pre-tax charges decreased to $13.9 million from $36.9 million year-over-year.